COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

30,209 Articles (22,213 medRxiv, 7,996 bioRxiv)

Most recent first Previous |  Page 1139: Articles 11381-11390  | Next

Early immunologic response to mRNA COVID-19 vaccine in patients receiving biologics and/or immunomodulators.
Rodriguez-Marrtino, E., Medina-Prieto, R., Santana-Bagur, J., Sante, M., Pantoja, P., Espino, A. M., Sariol, C. A., Torres, E. A.
10.1101/2021.09.11.21263211 — Posted: 2021-09-15
What pushed Israel out of herd immunity? Modeling COVID-19 spread of Delta and Waning immunity
De-Leon, H., Aran, D.
10.1101/2021.09.12.21263451 — Posted: 2021-09-15
Scale-free dynamics of Covid-19 in a Brazilian city
Policarpo, J. M. P., Ramos, A. A. G. F., Dye, C., Faria, N. R., Leal, F. E., Moraes, O. J. S., Parag, K. V., Peixoto, P. S., Sabino, E. C., Nascimento, V. H., Deppman, A.
10.1101/2021.09.10.21263332 — Posted: 2021-09-15
Effectiveness of Mass Vaccination in Brazil against Severe COVID-19 Cases
Villela, D. A. M., de Noronha, T. G., Bastos, L. S., Pacheco, A. G. F., Cruz, O. G., Carvalho, L. M., Codeco, C. T., Gomes, M. F. C., Coelho, F. C., Freitas, L. P., Lana, R. M., Porto, V. B. G., Camacho, L. A., Struchiner, C. J.
10.1101/2021.09.10.21263084 — Posted: 2021-09-15
Spread of Gamma (P.1) sub-lineages carrying Spike mutations close to the furin cleavage site and deletions in the N-terminal domain drives ongoing transmission of SARS-CoV-2 in Amazonas, Brazil
Naveca, F. G., Nascimento, V., Souza, V., Corado, A. L., Nascimento, F., Silva, G., Mejia, M. C., Brandao, M. J., Costa, A., Duarte, D., Pessoa, K., Jesus, M., Goncalves, L., Fernandes, C., Mattos, T., Abdalla, L., Santos, J. H., Martins, A., Chui, F. M., Val, F. F., Melo, G. C. d., Simao, M. X., Sampaio, V. d. S., Mourao, M. P., Lacerda, M. V., Batista, E. L., Magalhaes, A. L., Dabilla, N., Pereira, L. C. G., Vinhal, F., Miyajima, F., Dias, F. S., dos Santos, E. R., Coelho, D., Ferraz, M., Lins, R., Wallau, G. L., Delatorre, E., Gräf, T., Siqueira, M. M., Resende, P. C., Bello, G.
10.1101/2021.09.12.21263453 — Posted: 2021-09-15
Spike Protein NTD mutation G142D in SARS-CoV-2 Delta VOC lineages is associated with frequent back mutations, increased viral loads, and immune evasion
Shen, L., Triche, T. J., Dien Bard, J., Biegel, J. A., Judkins, A. R., Gai, X.
10.1101/2021.09.12.21263475 — Posted: 2021-09-15 Discussion: Onsite
Association between work attendance when experiencing fever or cold symptoms and company characteristics and socioeconomic status in the COVID-19 pandemic in Japanese workers: a cross-sectional study
Mizuki, K., Okawara, M., Hino, A., Ando, H., Nagata, T., Tateishi, S., Tsuji, M., Matsuda, S., Fujino, Y.
10.1101/2021.09.13.21263476 — Posted: 2021-09-15
Role of sleep quality in the acceleration of biological aging and its potential for preventive interaction on air pollution insults: findings from the UK Biobank cohort
Gao, X., Huang, N., Huang, T.
10.1101/2021.08.27.457922 — Posted: 2021-09-15
Synthetic Multiantigen MVA Vaccine COH04S1 Protects Against SARS-CoV-2 in Syrian Hamsters and Non-Human Primates
Chiuppesi, F., Nguyen, V. H., Park, Y., Contreras, H., Karpinski, V., Faircloth, K., Nguyen, J., Kha, M., Johnson, D., Martinez, J., Iniguez, A., Zhou, Q., Kaltcheva, T., Frankel, P., Kar, S., Sharma, A., Andersen, H., Lewis, M. G., Shostak, Y., Wussow, F., Diamond, D. J.
10.1101/2021.09.15.460487 — Posted: 2021-09-15
Characterizing flexibility and mobility in the natural mutations of the SARS-CoV-2 spikes
Panayis, J., Roemer, N. S., Bellini, D., Wallis, K., Roemer, R. A.
10.1101/2021.09.14.460264 — Posted: 2021-09-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).